Pro-Dex (PDEX) Planet MicroCap Las Vegas 2026 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Las Vegas 2026 summary
18 Jun, 2026Company history and turnaround
Faced significant losses in 2011–2012, prompting a board overhaul and cost-cutting focus.
Reduced executive overhead and implemented strict cost controls, leading to improved financials.
Invested in technology, acquired a second facility, and established long-term OEM contracts.
Employee base grew from 55 to 208, with many original staff retained through challenging periods.
Share buybacks reduced outstanding shares from over 4 million to 3.2 million in ten years.
Product innovation and market position
Developed proprietary Adaptive Torque Limiting technology for surgical screwdrivers, enabling precise screw placement.
Expanded product applications from cranial to thoracic, extremities, and spine surgeries.
Five customers now use exclusive torque-limiting screwdrivers, with strong surgeon feedback.
Repair services account for about 10% of business, with high margins and robust product longevity.
Off-the-shelf branded products allow smaller customers access to advanced technology at lower entry costs.
Growth strategy and future plans
Aggressive growth plans include expanding branded product lines and developing new articulating and spinal drivers.
Actively pursuing mergers and acquisitions, targeting family-owned MedTech firms for diversification.
Recent acquisition of APM, a long-time supplier, to enhance automation and add aerospace/defense capabilities.
Business development team expansion and website investment underway to drive new customer engagement.
Focus on leveraging engineering services and supporting startups and inventors for future growth.
Latest events from Pro-Dex
- Rapid revenue growth and proprietary tech fuel leadership in orthopedic device markets.PDEX
Investor presentation17 Jun 2026 - Record revenue and net income growth, driven by acquisitions and investment gains.PDEX
Q3 202630 Apr 2026 - Strong sales, new products, and investment gains boosted earnings and cash flow.PDEX
Q2 202629 Jan 2026 - Shareholders to vote on director elections, auditor, executive pay, and equity plan extension.PDEX
Proxy Filing1 Dec 2025 - Shareholders to vote on board elections, auditor ratification, and executive pay amid record growth.PDEX
Proxy Filing1 Dec 2025 - Annual meeting seeks votes on directors, auditor, pay, and equity plan extension.PDEX
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and say-on-pay vote set for November 21, 2024.PDEX
Proxy Filing1 Dec 2025 - Revenue and net income surged on strong device sales and investment gains, but margin fell.PDEX
Q1 202630 Oct 2025 - Revenue and profit surged on orthopedic product shipments, but inventory controls remain a risk.PDEX
Q2 202516 Oct 2025